Loading company…
Riskpilot
← Back to search
Sign in
Get full access
KIVAL ApS
APS
Dissolved
CVR 66263428
Bolbrovej 11B
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 1980
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
—
EBITDA margin
—
+14% vs 2023
Equity ratio
70.4%
Financial strength
Net profit 2024
DKK -524K
+22% vs 2023
EBITDA — year on year
DKK millions
1M
1M
0M
-1M
-1M
0M
2020
0M
0%
2021
1M
+100%
2022
-1M
-200%
2023
-1M
0%
2024
Key figures
Annual report 2024
Revenue
—
—
EBITDA
DKK -519K
+14%
Net profit
DKK -524K
+22%
Total assets
DKK 232K
-68%
Equity
DKK 163K
-76%
Employees
1
—
Company information
Legal name
KIVAL ApS
CVR number
66263428
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. oktober 1980
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-03-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene
Contact
Address
Bolbrovej 11B
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Hørsholm
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
1M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
1M
2022
-1M
2023
-1M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
557
600
1.250
-318
—
Staff expenses
-600
-600
-510
-285
-210
EBITDA
-43
-0
740
-603
-519
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-43
-0
740
-603
-519
Net financials
-64
107
-81
-66
-5
Profit before tax
-107
107
659
-669
-524
Tax
-24
24
145
-0
-0
Net profit
-84
84
514
-669
-524
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
913
1.096
1.414
727
232
Equity
759
843
1.357
687
163
Long-term debt
0
0
0
0
0
Short-term debt
153
253
57
39
69
Total debt
153
253
57
39
69
Financial ratios
5-year trend
EBITDA margin
-51893400.0%
This company
15.8%
Market median
-328439341% vs market
2020
2024
Equity ratio
70.4%
This company
38.2%
Market median
+84% vs market
2020
2024
Return on equity
-320.6%
This company
18.4%
Market median
-1842% vs market
2020
2024
Net profit margin
-52378500.0%
This company
8.1%
Market median
-646648248% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.42×
This company
0.62×
Market median
+32% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2023-04-01 – 2024-03-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-04-01 – 2023-03-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-04-01 – 2022-03-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-04-01 – 2021-03-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2019-04-01 – 2020-03-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
BM
Bengt Møller
Audit
Audit
1980 – 2009
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Kirsten Vendelbo
Individual
100%
100%
1980
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of KIVAL ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Bengt Møller
Audit
0 companies